Accurately quantify the level of phosphorylated EGFR in your cells. The in situ kit includes primary Navenibodies specific to phosphorylated EGFR, and all other reagents needed to run the assay.
Visualize phosphorylated PD1 in situ. The kit includes primary Navenibodies specific to phosphorylated PD1 and all other reagents needed to run the assay. Chromogenic detection and bright-field read-out.
Visualize phosphorylated PD1 in situ. The kit includes primary Navenibodies specific to phosphorylated PD1 and all other reagents needed to run the assay. Chromogenic detection and bright-field read-out.
Phosphorylated HER2, a well-known cancer marker, is now possible to detect in situ. The kit includes primary Navenibodies specific to phosphorylated HER2, and all other reagents needed to run the assay.
Visualize phosphorylated VEGFR2 in situ. The kit includes primary Navenibodiesspecific to phosphorylated VEGFR2and all other reagents needed to run the assay.
Quantify phosphorylated Met in situ. The kit includes primary Navenibodies specific to phosphorylated Met, and all other reagents needed to run the assay.
Detection of phosphorylated PDGFR-beta in situ – now with high signal to noise ratio. The kit includes primary Navenibodies specific to phosphorylated PDGFR-beta, and all other reagents needed to run the assay.
